• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Plasma phentermine levels, weight loss and side-effects.

作者信息

Douglas A, Douglas J G, Robertson C E, Munro J F

出版信息

Int J Obes. 1983;7(6):591-5.

PMID:6654575
Abstract

Fifty women with refractory obesity received phentermine resinate. Seven were withdrawn because of side-effects: three developed severe headaches, one each hypertension, depressive symptoms, breathlessness and palpitations with irritability. The mean weight loss in the 34 who completed the 20-week study was 6.4 kg. Nine lost 10 kg or more. Sustained appetite suppression was related to weight loss. Plasma phentermine concentrations did not correlate with the severity of the obesity problem, the degree of subjective anorexia or with weight loss. Poor initial response to standard dosage of phentermine is unlikely to improve with higher dosage. The individual's response to phentermine is unpredictable and appears to relate to factors other than the plasma drug concentration.

摘要

相似文献

1
Plasma phentermine levels, weight loss and side-effects.
Int J Obes. 1983;7(6):591-5.
2
Topiramate + phentermine. An excessively dangerous appetite-suppressant combination.托吡酯+芬特明。一种极其危险的食欲抑制组合。
Prescrire Int. 2013 Mar;22(136):61-4.
3
Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.苯丁胺、托吡酯及其联合用药治疗脂肪代谢障碍(“病态肥胖”)和代谢性疾病。
Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1777-801. doi: 10.1586/erc.10.125. Epub 2010 Aug 16.
4
Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
Curr Ther Res Clin Exp. 1972 Nov;14(11):726-38.
5
A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.一项关于体重控制的双盲临床试验。单独及联合使用芬氟拉明和苯丁胺。
Arch Intern Med. 1984 Jun;144(6):1143-8.
6
Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial.在一项多中心试验中,普兰林肽与西布曲明或 phentermine 联合使用可增强减肥效果。
Obesity (Silver Spring). 2010 Sep;18(9):1739-46. doi: 10.1038/oby.2009.478. Epub 2010 Jan 21.
7
A case of profound weight loss secondary to use of phentermine.一例因使用芬特明导致的严重体重减轻病例。
J Miss State Med Assoc. 2009 Dec;50(12):407-15.
8
Effects on weight reduction and safety of short-term phentermine administration in Korean obese people.短期服用苯丁胺对韩国肥胖人群体重减轻及安全性的影响。
Yonsei Med J. 2006 Oct 31;47(5):614-25. doi: 10.3349/ymj.2006.47.5.614.
9
Topiramate and phentermine: a long story...托吡酯与芬特明:一段漫长的故事……
Prescrire Int. 2013 Mar;22(136):62.
10
Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.苯丁胺/托吡酯用于减肥及治疗肥胖相关的不良代谢后果。
Drugs Today (Barc). 2011 Dec;47(12):903-14. doi: 10.1358/dot.2011.47.12.1718738.

引用本文的文献

1
Natural Chalcones for the Management of Obesity Disease.天然查耳酮类化合物在肥胖病管理中的应用。
Int J Mol Sci. 2023 Nov 3;24(21):15929. doi: 10.3390/ijms242115929.
2
Induction of thermogenic adipocytes: molecular targets and thermogenic small molecules.诱导产热脂肪细胞:分子靶点和产热小分子。
Exp Mol Med. 2017 Jul 7;49(7):e353. doi: 10.1038/emm.2017.70.
3
Off-label drugs for weight management.用于体重管理的非标签药物。
Diabetes Metab Syndr Obes. 2017 Jun 10;10:223-234. doi: 10.2147/DMSO.S95299. eCollection 2017.
4
Management of obesity and cardiometabolic risk - role of phentermine/extended release topiramate.肥胖与心脏代谢风险的管理——盐酸苯丁胺/缓释托吡酯的作用
Diabetes Metab Syndr Obes. 2014 Feb 12;7:35-44. doi: 10.2147/DMSO.S38979. eCollection 2014.
5
Phentermine, sibutramine and affective disorders.苯丙醇胺、西布曲明与情感障碍。
Clin Psychopharmacol Neurosci. 2013 Apr;11(1):7-12. doi: 10.9758/cpn.2013.11.1.7. Epub 2013 Apr 24.
6
Neuropsychiatric adverse effects of centrally acting antiobesity drugs.中枢作用减肥药的神经精神不良反应。
CNS Neurosci Ther. 2011 Oct;17(5):490-505. doi: 10.1111/j.1755-5949.2010.00172.x. Epub 2010 Jul 7.
7
RE: Pulmonary hypertension associated with use of phentermine?关于:使用苯丁胺导致的肺动脉高压?
Yonsei Med J. 2011 Sep;52(5):869-70. doi: 10.3349/ymj.2011.52.5.869.
8
Safety of drug therapies used for weight loss and treatment of obesity.用于减肥和肥胖症治疗的药物疗法的安全性。
Drug Saf. 2006;29(4):277-302. doi: 10.2165/00002018-200629040-00001.
9
Appetite suppressants. A review.食欲抑制剂。一篇综述。
Drugs. 1992 Jun;43(6):820-36. doi: 10.2165/00003495-199243060-00003.